Merit Medical Systems Research and Development Expenses 2010-2023 | MMSI
Merit Medical Systems research and development expenses from 2010 to 2023. Research and development expenses can be defined as an expense arising from studies and product development processes.
Merit Medical Systems Annual Research and Development Expenses
(Millions of US $) |
| 2023 |
$83 |
| 2022 |
$76 |
| 2021 |
$71 |
| 2020 |
$58 |
| 2019 |
$66 |
| 2018 |
$60 |
| 2017 |
$51 |
| 2016 |
$45 |
| 2015 |
$41 |
| 2014 |
$37 |
| 2013 |
$34 |
| 2012 |
$28 |
| 2011 |
$22 |
| 2010 |
$15 |
| 2009 |
$11 |
Merit Medical Systems Quarterly Research and Development Expenses
(Millions of US $) |
| 2023-12-31 |
$22 |
| 2023-09-30 |
$20 |
| 2023-06-30 |
$20 |
| 2023-03-31 |
$21 |
| 2022-12-31 |
$20 |
| 2022-09-30 |
$19 |
| 2022-06-30 |
$18 |
| 2022-03-31 |
$17 |
| 2021-12-31 |
$20 |
| 2021-09-30 |
$17 |
| 2021-06-30 |
$18 |
| 2021-03-31 |
$16 |
| 2020-12-31 |
$15 |
| 2020-09-30 |
$14 |
| 2020-06-30 |
$14 |
| 2020-03-31 |
$15 |
| 2019-12-31 |
$16 |
| 2019-09-30 |
$17 |
| 2019-06-30 |
$16 |
| 2019-03-31 |
$16 |
| 2018-12-31 |
$15 |
| 2018-09-30 |
$15 |
| 2018-06-30 |
$15 |
| 2018-03-31 |
$14 |
| 2017-12-31 |
$13 |
| 2017-09-30 |
$13 |
| 2017-06-30 |
$13 |
| 2017-03-31 |
$13 |
| 2016-12-31 |
$12 |
| 2016-09-30 |
$11 |
| 2016-06-30 |
$11 |
| 2016-03-31 |
$11 |
| 2015-12-31 |
$11 |
| 2015-09-30 |
$11 |
| 2015-06-30 |
$9 |
| 2015-03-31 |
$10 |
| 2014-12-31 |
$10 |
| 2014-09-30 |
$9 |
| 2014-06-30 |
$10 |
| 2014-03-31 |
$9 |
| 2013-12-31 |
$9 |
| 2013-09-30 |
$7 |
| 2013-06-30 |
$9 |
| 2013-03-31 |
$9 |
| 2012-12-31 |
$8 |
| 2012-09-30 |
$7 |
| 2012-06-30 |
$7 |
| 2012-03-31 |
$6 |
| 2011-12-31 |
$6 |
| 2011-09-30 |
$5 |
| 2011-06-30 |
$5 |
| 2011-03-31 |
$5 |
| 2010-12-31 |
$5 |
| 2010-09-30 |
$4 |
| 2010-06-30 |
$4 |
| 2010-03-31 |
$3 |
| 2009-12-31 |
$3 |
| 2009-09-30 |
$3 |
| 2009-06-30 |
$3 |
| 2009-03-31 |
$2 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical & Dental Supplies |
$4.697B |
$1.257B |
|
Merit Medical Systems, Inc. provides various peripheral and cardiac intervention products to cure cardiac conditions specific to interventional cardiology and electrophysiology. The company offers products focused in five core product groups: peripheral intervention, cardiac intervention, interventional oncology and spine, cardiovascular and critical care as well as endoscopy. However, the company operates in two revenue segments: Cardiovascular and Endoscopy Devices.
|
